NOUS-209 shows potential to intercept cancer in its early stages
Category: News
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
The update is aimed at strengthening local and national surveillance
The company is preparing to submit the results to the FDA this year
The agency has launched a whole genome sequencing service to monitor the virus
VIDAR-1 trial marks company’s clinical-stage debut
Collaboration brings remote care to cancer patients
EC extends brexpiprazole indication to include adolescents
Immunoglobulin therapy improves mobility in phase 2/3 study
Phase 2a TREE study assesses safety and efficacy of leriglitazone